In June, 2009, an article in the Boston Globe described how the Boston area based biotechnology company Genzyme sold some astonishlingly expensive drugs, using
a remarkable business strategy : In countries from Colombia to Taiwan to Libya, the Cambridge firm has compiled an extraordinary track record of searching out patients like Tania, providing desperately needed treatment, and then successfully pressing their governments, even poor ones, to pay full price for the most expensive drugs in the...
After Manufacturing Problems, Genzyme CEO's Golden...
In late 2009, I posted about problems at a Genzyme plant that manufactured some fabulously expensive drugs, e.g. Cerezyme whose cost to patients approximated $160,000 a year. We thought then...
Sanofi-Aventis to buy Genzyme for $20.1 bln cash
PARIS (AP) -- French drug maker Sanofi-Aventis SA has agreed to buy Genzyme Corp. in a sweetened all-cash deal that values the U.S. biotechnology company at $20.1 billion, ending months of...
Not "the Best and the Brightest" - Drug Marketers and...
A combined investigative reporting effort by Pro Publica, partnering with the Boston Globe, Consumers Reports, the Chicago Tribune, National Public Radio, the Public Broadcasting System on...
Country Save HE Laundry Detergent, Powder, 160-Load,...
Yogi Tea Calm, Bedtime, Tea Bags, 16-Count Boxes...
Post new comment